期刊
NATURE CELL BIOLOGY
卷 13, 期 8, 页码 981-U245出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ncb2279
关键词
-
类别
资金
- Institut PASTEUR
- Institut CURIE
- CNRS
- INSERM
- Agence Nationale pour la Recherche [ANR 07 JCJC 0089]
- Schlumberger Foundation for Education and Research-FSER
- Ministere de la Recherche et de l'Enseignement Superieur
- Association pour la Recherche sur le Cancer
- Agence Nationale de la Recherche (ANR) [ANR-07-JCJC-0089] Funding Source: Agence Nationale de la Recherche (ANR)
Abscission is the least understood step of cytokinesis. It consists of the final cut of the intercellular bridge connecting the sister cells at the end of mitosis, and is thought to involve membrane trafficking as well as lipid and cytoskeleton remodelling(1-6). We previously identified the Rab35 GTPase as a regulator of a fast recycling endocytic pathway that is essential for post-furrowing cytokinesis stages(7). Here, we report that the phosphatidylinositol-4,5-bisphosphate (PtdIns(4, 5)P(2)) 5-phosphatase OCRL, which is mutated in Lowe syndrome patients(8,9), is an effector of the Rab35 GTPase in cytokinesis abscission. GTP-bound (active) Rab35 directly interacts with OCRL and controls its localization at the intercellular bridge. Depletion of Rab35 or OCRL inhibits cytokinesis abscission and is associated with local abnormal PtdIns (4, 5)P(2) and F-actin accumulation in the intercellular bridge. These division defects are also found in cell lines derived from Lowe patients and can be corrected by the addition of low doses of F-actin depolymerization drugs. Our data demonstrate that PtdIns(4, 5)P(2) hydrolysis is important for normal cytokinesis abscission to locally remodel the F-actin cytoskeleton in the intercellular bridge. They also reveal an unexpected role for the phosphatase OCRL in cell division and shed new light on the pleiotropic phenotypes associated with Lowe disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据